Medtronic HR-ACT (High Range Activated Clotting Time Cartridges), REF 402-03 — FDA record Z-0539-2026

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Oct 20, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Medtronic HR-ACT (High Range Activated Clotting Time Cartridges), REF 402-03
Reason
Medtronic personnel observed trace amounts of dry blood on the external carton label and Instructions for Use (IFU) in five boxes of one lot of ACT Cartridges.
Classification
Class II
Recalling firm
Medtronic Perfusion Systems
Quantity
3850 units
Agency-reported status
Ongoing
Source record identifier
Z-0539-2026

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI/DI 20763000433844, Lot Number 232135734

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Nationwide distribution in the states of Hawaii and New York.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Nov 26, 2025
Recall initiation date
Oct 20, 2025
Center classification date
Nov 18, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records